RE:Recession analysisRBC today lowered target price to $37, but actually RAISED estimates for HCG. The lower target was part of a report that lowered the target for all companies under coverage. RBC's estimate now for earnings for 2023 is $6.97, up from $6.49. So the stock is at 3.6x earnings.
HermannHaller wrote: According to TD, in a 'severe recession' HCG still makes $3.86 EPS next year. That's the worst case scenario they model, they don't expect a severe recession. The analyst forecast is for $6.12 EPS.
Comforting to know that the company would still be profitable, obviously growing book value, and able to pay a big dividend under those conditions.